Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD

Wen-Jan Tuan,a,⁎ Dara E. Babinski,b David P. Rabago,a,b,c and Aleksandra E. Zgierskac Abstract Adults with attention deficit hyperactivity disorder (ADHD) have shown higher infection rates and worse outcomes from COVID-19. Stimulant medications are prescribed as the first-line treatment for ADHD in adults and mitigate risk of negative ADHD-related health outcomes, but little is known about the association between stimulant […]